All News

RheumNow Podcast square

Linger on the Fingers (9.6.2024)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week with a focus on fingers and better prescriptive follow through.

Read Article
urticaria

Urticarial Vasculitis Overview

Jack Cush, MD

Urticarial vasculitis is rare and the causes often go undiagnosed. A Medscape recent overview highlights key features in the diagnosis and management of this rare disorder.

Read Article
RheumNow Podcast square

Running with Data (8.30.2024)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com - including tips on steroids, MAS, and myositis testing.

Read Article
RheumNow Podcast square

All in the Family (8.23.2024)

Jack Cush, MD

Dr. Jack Cush picks highlight reports from the past week on RheumNow.com, with reports on the challenge of lupus nephritis, perplexing skin issues, you don't know JAK (about Tyk) and the value of a good family history.

Read Article
pedigree.genetics.family.history

A Family History of Arthritis?

Jack Cush, MD

Using data from the population based All of Us (AoU) Research Program, a self reported history of arthritis and related conditions was associated with an increased risk for arthritis, osteoporosis, and carpal tunnel syndrome.

Read Article
price%20dollar%20pill.jpg

ACR Applauds Lower Negotiated Prices for Common Arthritis Drugs

Jack Cush, MD

The American College of Rheumatology praised the recent announcement from the Centers for Medicare & Medicaid Services (CMS) that their initial drug pricing negotiations have reduced costs for select medications, including significantly lower prices for Enbrel and Stelara, which are frequently used to treat rheumatic diseases.

Read Article
RheumNow Podcast square

Higher Cancer Rates (8.16.2024)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, noting his concerns about diet, cancer, ILD, death and dosing challenges.

Read Article
EMA Updated overview of leflunomide (Arava) https://t.co/LbuqzDdTvf https://t.co/npfsRDdFiP

Links:

Dr. John Cush RheumNow ( View Tweet)
Good Clinical Practice Recommendations on Glucocorticoid Withdrawal and Adrenal Insufficiency The European Society of Endocrinology and Endocrine Society have jointly published a clinical guideline on the diagnosis and treatment of glucocorticoid-induced adrenal insufficiency,… https://t.co/GmQ5ypvqWP https://t.co/oab9qHpxSa
Dr. John Cush RheumNow ( View Tweet)
It takes >3-4 weeks of steroids (@ any dose >5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of <3-4 wks, irrespective of dose, DOES NOT require GC tapering https://t.co/o7tz1Am9pe https://t.co/CndfCYRApj

Links:

Dr. John Cush RheumNow ( View Tweet)
Birth Control Use in Lupus Published guidelines on lupus mgmt urge that female patients plan and prepare carefully for pregnancy, and use contraceptives when it's not intended -- but these reco’s are rarely followed, a registry study suggested. https://t.co/81mQbp5Sib https://t.co/NJmwxvtR44

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Backs FDA Rule Change on Interchangeable Biosimilars The ACR submitted comments to the FDA supporting their proposal to update the approval process for biosimilars’ interchangeability status. https://t.co/YD11qZJxIr https://t.co/tVij0ebwz4

Links:

Dr. John Cush RheumNow ( View Tweet)
New CDC guidance on Influenza vaccination!! All should recv, ideally in September or October. Immunocompromised (by meds or Dx) should recv Trivalent inactivated (IIV3s) & trivalent recombinant vaccine (RIV3), but not the live virus vaccine (LAIV3) https://t.co/r7euIb3BV9 https://t.co/Tx2pU2Onng

Links:

Dr. John Cush RheumNow ( View Tweet)
All in the Family (8.23.2024) Dr. Jack Cush picks highlight reports from the past week on RheumNow, with reports on the challenge of lupus nephritis, perplexing skin issues, you don't know JAK (about Tyk) and the value of a good family history. https://t.co/gwM77mJCnr https://t.co/HOGnymjhSZ

Links:

Dr. John Cush RheumNow ( View Tweet)
2024 Update of EULAR recommendations for the Treatment of Systemic Sclerosis https://t.co/52XEfgVCzZ https://t.co/d1zgTYUeOo

Links:

Dr. John Cush RheumNow ( View Tweet)
#Injection of PIP Mid joint capsule but above midline to avoid collateral ligament #ClinicalPearl #MedTwitter #MedEd #RheumX #RheumEd #MedX https://t.co/N9dBHB0rsf

Links:

Janet Pope Janetbirdope ( View Tweet)
ACR Applauds Lower Negotiated Prices for Common Arthritis Drugs The ACR praised the recent announcement from the CMS that their initial drug pricing negotiations have reduced costs for select medications, including significantly lower prices for Enbrel and Stelara, which are… https://t.co/GXl6y87ZaF https://t.co/A2N4Ehg8Dk
Dr. John Cush RheumNow ( View Tweet)
100 top-cited studies in #SLE. 60% from USA; half focused on underlying mechanisms #1 1982 1982 Revised Criteria for.. Classification ..SLE #2 Updated ACR Criteria... #3 Derivation of SLEDAI https://t.co/g3fcUqtsct https://t.co/HlGfGC4aci

Links:

Dr. John Cush RheumNow ( View Tweet)
🔥 One of the most important articles of the year showing medical evidence for disease-modifying (organ damage prevention) therapies in #SLE #lupus: CLICK 👉 https://t.co/Qmia9Gc8mu Kudos to the authors for such an important piece of work. Open up the table in the article and… https://t.co/z9osFAavud https://t.co/lWjkwMEHrq

Links:

Donald Thomas, MD lupuscyclopedia ( View Tweet)
Hispanic Patients With Dermatomyositis JAMA Dermatology has published a review of dermatomyositis (DM), focusing on similar and different manifestations of DM. https://t.co/HydzbzTJR4 https://t.co/KJs681ySO7

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×